New Hidradenitis Suppurativa Findings from Institute for Cancer Research and Treatment (IRCCS) Published (Health-related quality of life and clinical characteristics of hidradenitis suppurativa in a paediatric population).

A recent report from the Institute for Cancer Research and Treatment (IRCCS) discusses the impact of hidradenitis suppurativa (HS) on the quality of life of pediatric patients. The study highlights the need for early diagnosis, education, and psychological support for both pediatric and adult patients with HS. A multidisciplinary approach involving specialists and primary care providers is recommended to improve care and manage comorbidities and psychological issues in patients with HS. The full article can be accessed for free at the Dermatology Reports website. [Extracted from the article]